Intervertebral Disc Degeneration and Regeneration: New Molecular Mechanisms and Therapeutics
Author Information
Author(s): Taylor William, Erwin William Mark
Primary Institution: University of California at San Diego; University of Toronto
Hypothesis
Can new molecular therapies effectively address intervertebral disc degeneration and associated pain?
Conclusion
Recent research has identified potential breakthrough technologies for treating degenerative disc disease, but these have yet to be translated into clinical practice.
Supporting Evidence
- Degeneration of the intervertebral disc is a major cause of disability worldwide.
- Current therapies have not achieved meaningful clinical impact.
- Breakthrough technologies include advanced imaging and novel molecular therapies.
Takeaway
Doctors are trying to find better ways to help people with back pain from bad discs, but it's really hard because the discs are in a tricky spot and don't get enough blood.
Limitations
The review highlights the challenges in developing effective therapies due to the unique environment of the intervertebral disc and the complexity of pain mechanisms.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website